Current through Register Vol. 49, No. 10, October, 2024
Rule 006.06.20-003 - Thoroughbred Rule 1217D(5)(5) The administration of clenbuterol or any other B2 agonist to a horse within the sixty (60) day period immediately preceding a race in which the horse participates at Oaklawn is prohibited. The presence of clenbuterol or any other B2 agonist in a horse's urine, serum, plasma, or hair at a level of detection indicating use within said sixty (60) day period shall be a violation of this rule.006.06.20 Ark. Code R. 003
Adopted by Arkansas Register Volume MMXXI Number 01, Effective 1/22/2021